UNLIMITED TURBO SHORT - BAYER | Market Closed - Euronext Paris 17:30:01 10/06/2024 BST | ||
| 3.625 EUR | +1.97% |
|
| Current month | +1.97% | ||
| 1 month | +4.32% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BAYER AG
| Date | Price | Change |
|---|---|---|
| 10/06/24 | 3.625 | +1.97% |
| 07/06/24 | 3.555 | +0.28% |
| 06/06/24 | 3.545 | +0.85% |
| 05/06/24 | 3.515 | -0.57% |
| 04/06/24 | 3.535 | +0.57% |
Real-time Euronext Paris
Last update June 10, 2024 at 05:30 pm
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | PUT |
| Underlying | BAYER AG |
| Issuer | 
BNP Paribas
|
| G7LKB | |
| ISIN | FRBNPP05DPA2 |
| Date issued | 10/02/2023 |
| Strike | 62.68 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.31 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.865 € |
|---|---|
| Lowest since issue | 0.51 € |
Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
-
Consensus: Bayer AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
27.48
EUR
Average target price
36.18
EUR
Spread / Average Target
+31.69%
- Stock Market
- Certificates
- G7LKB Certificat
